Leg ulcer healing in a patient with non–transfusion-dependent β-thalassemia treated with luspatercept. The patient received 0.4 mg/kg of luspatercept in the initial stage of the study and up to 1.25 mg/kg of luspatercept in the extension stage. The image example shown is representative of an ulcer that healed within 6 weeks.